Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze ALNY stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ALNY investment potential.

What is ALNY stock price today?

Get real-time ALNY stock price, historical data, and price charts on Financhill. Track ALNY performance with our advanced analysis tools.

Is ALNY a good investment?

Evaluate ALNY investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ALNY stock?

To buy ALNY stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ALNY?

View detailed market capitalization data and company valuation metrics for ALNY on our comprehensive analysis page.

What is the P/E ratio of ALNY?

Use our fundamental analysis tools to view ALNY P/E ratio and compare valuation metrics with industry peers.

What are ALNY earnings?

View ALNY earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Alnylam Pharmaceuticals, Inc. 10K Form

Buy

ALNY
Alnylam Pharmaceuticals, Inc.

Last Price:

$465.37

Seasonality Move:

6.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-02	10Q	ALNY/Alnylam Pharmaceuticals, Inc. Quarterly
2023-11-02	10Q	ALNY/Alnylam Pharmaceuticals, Inc. Quarterly
2023-08-03	10Q	ALNY/Alnylam Pharmaceuticals, Inc. Quarterly
2023-05-04	10Q	ALNY/Alnylam Pharmaceuticals, Inc. Quarterly
2022-10-27	10Q	ALNY/Alnylam Pharmaceuticals, Inc. Quarterly
2022-07-28	10Q	ALNY/Alnylam Pharmaceuticals, Inc. Quarterly

Receive ALNY News And Ratings

See the #1 stock for the next 7 days that we like better than ALNY

ALNY Financial Statistics

Sales & Book Value

Annual Sales:	$2.2B
Cash Flow:	$313M
Price / Cash Flow:	276.84
Annual Sales:	$1.77
Price / Book:	262.85

Profitability

EPS (TTM):	0.24050
Net Income (TTM):	$43.6M
Gross Margin:	$1.9B
Return on Equity:	31.15%
Return on Assets:	0.98%

Alnylam Pharmaceuticals, Inc. Earnings Forecast

Key Alnylam Pharmaceuticals, Inc. Financial Ratios

The Gross Profit Margin over the past 20 years for ALNY is 85.62%.
The Selling, General & Administrative Expenses for ALNY have been equal to 43.39% of Gross Profit Margin.
The Research & Development expenses have been 50.09% of Revenue.
The Net Earning history of ALNY is -12.37% of Total Revenues.
Per Share Earnings over the last 23 years have been positive in 11 years.

Alnylam Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	ALNY
CUSIP:	02043Q
Website:	alnylam.com

Debt

Debt-to-Equity Ratio:	11.86
Current Ratio:	2.54
Quick Ratio:	2.37

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	43.86

ALNY Technical Analysis vs Fundamental Analysis

Buy

Alnylam Pharmaceuticals, Inc. (ALNY) is a Buy

Is Alnylam Pharmaceuticals, Inc. a Buy or a Sell?

Alnylam Pharmaceuticals, Inc. stock is rated a Buy

The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $465.34. The Score for ALNY is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.